Injectable Cytotoxic Drugs Market Size to Surpass USD 26.50 Billion by 2030, exhibiting a CAGR of 5.4%


According to the report by Fortune Business Insights, the global injectable cytotoxic drugs market size is projected to reach USD 26.50 billion by 2030, at a CAGR of 5.4% during the forecast period, 2023-2030

Injectable Cytotoxic Drugs Market

Injectable Cytotoxic Drugs Market Forecast (2023-2030)
Injectable Cytotoxic Drugs Market Forecast (2023-2030)

Pune, India, Oct. 26, 2023 (GLOBE NEWSWIRE) — The global injectable cytotoxic drugs market size is projected to reach from USD 18.29 billion in 2023 to USD 26.50 billion by 2030, recording a CAGR of 5.4% during the forecast period. The rising prevalence of cancer, multiple sclerosis, and other chronic diseases is predicted to boost the injectable cytotoxic drugs market growth.

Fortune Business Insights™ displays this information in a report titled, “Injectable Cytotoxic Drugs Market, 2023-2030.”

Notable Industry Development:

  • June 2023: The U.S. FDA announced that it had allowed temporary imports of 50-milligram vials of cisplatin, an injectable chemotherapy drug, to boost its supplies in the U.S.

Request a Free Sample PDF:

Key Takeaways:

  • Increasing prevalence of cancer and the high dependence on cytotoxic drugs for its treatment augmenting the market growth during forecast period.
  • Cytotoxic drugs, or chemotherapy, are also known for their major side effects, such as anemia, bone marrow depression, and follicle toxicity.
  • The North America injectable cytotoxic drugs market value stood at USD 8.44 billion in 2022.
  • higher adoption of cytotoxic drugs is estimated to propel the segment growth in the coming years.

List of key companies profiled in the report:

“Companies leading the global injectable cytotoxic drugs market are Johnson and Johnson Services Inc., (U.S.), Sanofi (France), Eli Lilly and Company (U.S.), Bristol-Myers Squibb Company (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), Novartis AG (Switzerland), Pfizer, Inc. (U.S.), Merck & Co. Inc. (U.S.), Amgen, Inc. (U.S.)”

Report Scope & Segmentation

Report Coverage Details
Forecast Period 2023 to 2030
Forecast Period 2023 to 2030 CAGR 5.4%
2030 Value Projection USD 26.50 Billion
Base Year 2022
Market Size in 2023 USD 18.29 billion
Historical Data 2019 to 2021
No. of Pages 158
Segments covered By Product, Distribution Channel, and Region

Browse Complete Report Details:


Antimetabolites Segment to Gain Traction Due to Their High Use in Oncology Treatments

Based on drug class, the market is split into alkylating drugs, cytotoxic antibodies, antimetabolites, plant alkaloids, and others. The antimetabolites segment held the largest injectable cytotoxic drugs market share in 2022 due to extensive use in treating oncology and rheumatoid disorders.

Oncology Segment Takes the Lead as Demand for Effective Cancer Treatments Grows

In terms of application, the market has been categorized into oncology, multiple sclerosis, rheumatoid arthritis, and others. The oncology segment dominated the global market due to the increasing cases of cancer and the rising demand for effective treatments.

Hospital Pharmacies Segments Leads Market, Catering to Demand for Expert Administration of Injectable Cytotoxic Drug

Based on distribution channel, the market is segmented into hospital pharmacies, drug stores & retail pharmacies, and online pharmacies. The hospital pharmacies segment leads the global market as a wide range of injectable cytotoxic drugs require the expertise of highly skilled healthcare professionals to administer them.

With respect to region, the market covers North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.

By Drug Class

  • Alkylating Drugs
  • Cytotoxic Antibodies
  • Antimetabolites
  • Plant Alkaloids
  • Others

By Application

  • Oncology
  • Rheumatoid Arthritis
  • Multiple Sclerosis
  • Others

By Distribution Channel

  • Hospital Pharmacies
  • Drug Stores & Retail Pharmacies
  • Online Pharmacies

By Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Quick Buy – Injectable Cytotoxic Drugs Market Research Report:

Drivers and Restraints:

Growing Reliance On Cytotoxic Drugs to Treat Chronic Ailments to Fuel Market Growth

Cancer, having numerous causes, calls for effective standard treatments such as radiation therapy and chemotherapy, which are highly sought after by cancer patients. Injectable cytotoxic drugs are used as the first line of treatment for these patients. Many upcoming therapies, immunotherapy, and targeted therapy administer medicines in combination with cytotoxic/chemotherapy drugs. These factors are expected to boost market growth.

However, the rising availability of alternate therapies to treat cancer might restrain market progress.

Regional Insights:

North America to Dominate Market Due to Rising Cancer Cases

North America is expected to hold the largest market share as the region witnesses a significant increase in people suffering from various types of cancer. Moreover, cancer patients are gaining easier access to medicines effective in treating cancer, further fueling the regional market development.

Europe is expected to grow at a notable pace due to factors such as favorable healthcare reimbursement policies, increasing expenditure on cancer & rheumatoid arthritis treatment, and growing government initiatives to improve patients’ access to chemotherapy medicines.

Competitive Landscape:

Key Market Players to Launch Cost-Effective Treatments to Retain Market Dominance

The injectable cytotoxic drugs market is highly fragmented and competitive due to the growing presence of regional as well as international companies. Johnson & Johnson Services Inc. dominated the market in 2022 by focusing on mergers and acquisitions. Moreover, many companies are introducing cost-effective treatments to increase their access to low- and middle-income patients, helping them cement their market positions.

Speak to Analyst:


How big is the Injectable Cytotoxic Drugs Market?

Injectable Cytotoxic Drugs Market size was USD 17.65 Billion in 2022. It is expected to reach USD 26.50 Billion by 2030.

How fast is the injectable cytotoxic drugs market growing?

The Injectable Cytotoxic Drugs Market will exhibit a CAGR of 5.4% during the forecast period, 2023-2030

Related Reports:

Rheumatoid Arthritis Testing Market Growth, Industry Analysis, Demand and Forecast

Immunology Market Size, Share, Opportunities & Analysis

Multiple Sclerosis Drugs Market Overview, Industry Share and Forecast

About Us:

Fortune Business Insights™ offers expert corporate analysis and accurate data, helping   organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

Contact Us:

Fortune Business Insights™ Pvt. Ltd.

9th Floor, Icon Tower,

Baner – Mahalunge Road,

Baner, Pune-411045,

Maharashtra, India.


U.S.: +1 424 253 0390

U.K.: +44 2071 939123

APAC: +91 744 740 1245

Email: [email protected]


Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. takes no editorial responsibility for the same.